Cover Image
市場調查報告書

全球遺傳基因檢驗市場考察,機會分析,市場佔有率,預測

Global Genetic Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 358657
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球遺傳基因檢驗市場考察,機會分析,市場佔有率,預測 Global Genetic Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年05月30日 內容資訊: 英文 140 Pages
簡介

遺傳基因檢驗,是關於染色體和蛋白質的變化,也就是遺傳基因的變化識別的醫學檢驗的一種。

本報告提供全球遺傳基因檢驗市場相關調查分析,市場概要,市場決策要素,各部門分析,市場區隔,競爭情形,各地區分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場考察
  • 競爭情形
  • 五力分析模型
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各類型
  • 各用途

第5章 各地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他
  • 其他

第6章 企業簡介

  • CEPHEID
  • DAAN DIAGNOSTICS LTD.
  • GENENTECH, INC.
  • GENOMICTREE, INC.
  • HTG MOLECULAR DIAGNOSTICS, INC.
  • ILLUMINA, INC
  • INTEGRAGEN S.A
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • LUMINEX CORPORATION
  • MOLECULARMD, CORP.
  • MYRIAD GENETICS, INC.
  • NATERA, INC.
  • OXFORD BIODYNAMICS LIMITED
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • PERKINELMER, INC.
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS LIMITED

圖表

目錄
Product Code: HBI-1331015

Genetic testing is a type of medical tests that identifies changes in chromosomes, proteins or in genes. The results of this type of tests confirms the genetic issues if any in patients. Genetic testing represents the most rapidly expanding segment in the molecular diagnostics market globally. Growing incidence of genetic diseases opens up new opportunities for genetic testing. The conversion of genetic testing from being a service-driven to a product-driven market is expected to provide a thrust to the diagnostic companies for the expansion of their business globally. The market for screening the Diagnostic, newborns, rare and fatal disorders, and predicting the probability of occurrence of diseases is likely to expand. Mainly, genetic tests to screen the newborns are expected to expand immensely over the coming years. Genetic testing is a sophisticated and typical form of medical testing to identify smallest changes in genes, proteins or in chromosomes that are associated with problematic diseases. The positivity or negativity of such tests can confirm suspected genetic condition and helps the doctors, physician with greater precision towards treating in genetic disorder.

Genetic testing is a bit expensive and cannot afford by all of the people. Due to time and knowledge required in the testing of rare diseases genetic testing is expensive procedure and cannot be adopted by normal peoples. This is the major drawback and it affects the growth and affects the market globally.

Genetic testing market growth is growing by increasing adoption in oncology applications, growing public awareness and demand for customized medicine. There is an increase in life expectancy and a growing aging population. There is rise in growth of chronic diseases and an increasing incidence of cancer etc. and these factors are boosting growth of the genetic testing market. The major role of genetics in diseases and health is now understood. This new combined knowledge with lower pricing is taking genetic testing market to the next level. The genetic testing market is growing rapidly in breadth and in the volume of tests creating new life in the industry.

Consumer demand for effective and safe way to treat diseases is rising. The scenario is beneficial for demand for genetic testing, the important role played by this tests to identifies the problematic chromosome, and genes are way too high. The genetic tests is very much helpful in identifying Cancer, cystic fibrosis, Alzheimer's. Molecular diagnostic involves analysis of DNA and RNA, this drives the increasing awareness of human genome. Faster screening, technological advancement, accurate detection and genetic testing. The major reason also includes favorable regulation environment, adoption of genetic testing by physicians in daily routine etc. Technological advancement in the field of genetic testing drives the physicians to determine the patients' health at different levels of treatment by diagnostic procedures.

With advancement in DNA analysis, the scope of genetic testing widens up in different areas, mainly in pharmacogenomics, predictive testing, and prenatal testing and so on. The early detection of genetic disorder reduces mortality rates. Genetic testing also enhances the early detection of breast cancer.

The global genetic testing market is segmented into type, application and regional outlook. In type market is divided into carrier testing, diagnostic testing, newborn screening and prenatal testing diagnostic testing is majorly used in the area to identify problematic chromosomes, genes and other proteins. In application market is segmented into cancer genetic testing, prenatal genetic testing, pharmacogenomics, and predisposition testing. Cancer genetic testing is having the largest market share in this segment. Cancer is very chronic disease and it took millions of lives per year. Genetic testing identifies the problematic alteration in the body. This save many lives of the people.

In regional outlook market is divided into North America, Asia pacific, Europe and rest of the world. U.S is the global leader in genetic testing market, the major reason in growth of this region is due to technological advancement in the field of genetic engineering, increasing prevalence of genetic diseases and high quality of infrastructure. Asia Pacific is the fastest growing market due to increase in number of ageing population, increase in problematic diseases, and advancement in medical field. China is the fastest growing country in this region. Rest of the world is also growing in this market, major countries like Dubai and South Africa. Europe is also sharing the market due to ageing population and increased disposal income of the people.

Major players like Roche Diagnostics Ltd., Pacific Bioscience Of California, Inc., Oxford Biodynamics, Myriad Genetics, Inc., Luminex Corporation, Laboratory Corporation Of America Holdings, Qiagen N.V etc. are using merger and acquisition, new products developments to expand.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
    • 2.3.1. INCREASING AGEING POPULATION
    • 2.3.2. R&D IN GENETIC FIELD
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP 3 GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. EARLY CONFIRMATION OF GENETIC DISORDER
    • 3.1.2. MINIMAL PROCEDURE RISK
    • 3.1.3. INCREASE OF PIPELINE GENETIC TESTS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. FALSE POSITIVE AND FALSE NEGATIVE RESULTS
    • 3.2.2. POTENTIAL ADVERSE PERSONAL OR SOCIETAL CONSEQUENCES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GENETIC COUNCELLING
    • 3.3.2. EXPANSION OF BREAST CANCER GENES TESTING MARKET
    • 3.3.3. NEW AND IMPROVED TECHNOLOGY
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGH PRICES OF TESTS
    • 3.4.2. RAW MATERIAL AND PRODUCTION COST IS HIGH
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. BY TYPE
    • 4.1.1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
    • 4.1.2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
    • 4.1.3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
    • 4.1.4. GLOBAL PRENATAL TESTING MARKET 2014-2022 ($MILLION)
  • 4.2. BY APPLICATION
    • 4.2.1. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
    • 4.2.2. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
    • 4.2.3. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
    • 4.2.4. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.1.1. UNITED STATES (U.S.) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.1.2. CANADA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 5.2. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.1. UNITED KINGDOM (UK) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.2. FRANCE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.3. GERMANY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.4. SPAIN GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.5. ITALY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.2.6. ROE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 5.3. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.3.1. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.3.2. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.3.3. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.3.4. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.3.5. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 5.4. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
    • 5.4.1. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.4.2. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
    • 5.4.3. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)

6. COMPANY PROFILING: - (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)

  • 1. CEPHEID
  • 2. DAAN DIAGNOSTICS LTD.
  • 3. GENENTECH, INC.
  • 4. GENOMICTREE, INC.
  • 5. HTG MOLECULAR DIAGNOSTICS, INC.
  • 6. ILLUMINA, INC
  • 7. INTEGRAGEN S.A
  • 8. LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 9. LUMINEX CORPORATION
  • 10. MOLECULARMD, CORP.
  • 11. MYRIAD GENETICS, INC.
  • 12. NATERA, INC.
  • 13. OXFORD BIODYNAMICS LIMITED
  • 14. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • 15. PERKINELMER, INC.
  • 16. QIAGEN N.V.
  • 17. ROCHE DIAGNOSTICS LIMITED

LIST OF TABLES

  • 1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
  • 2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
  • 3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
  • 4. GLOBAL PRENATAL TESTING 2014-2022 ($MILLION)
  • 5. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
  • 6. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
  • 7. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
  • 8. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)
  • 9. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 10. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 11. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 12. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
  • 2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
  • 3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
  • 4. GLOBAL PRENATAL TESTING 2014-2022 ($MILLION)
  • 5. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
  • 6. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
  • 7. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
  • 8. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)
  • 9. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 10. UNITED STATES (U.S.) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 11. CANADA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 12. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 13. UNITED KINGDOM (UK) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 14. FRANCE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 15. GERMANY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 16. SPAIN GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 17. ITALY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 18. ROE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 19. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 20. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 21. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 22. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 23. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 24. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 25. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
  • 26. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 27. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
  • 28. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
Back to Top